Market Overview - The Hang Seng Index closed at 25,768.08, down 291 points or 1.12% for the day, with a year-to-date increase of 0.54%[5] - The technology index fell by 2.26%, marking a year-to-date decline of 11.59%[5] - The total trading volume increased by 3.6% to HKD 370.55 billion[7] Key Stock Performances - ASMPT reported a net profit of HKD 902 million for the year ending December, a year-on-year increase of 161%[7] - Tencent (700.HK) decreased by 0.7%, while Alibaba (9988.HK) fell by 1.2%[7] - Longyuan Power (916.HK) is recommended for purchase at HKD 7.60, with a target price of HKD 8.20, reflecting a potential upside of 7.9%[16] Economic Indicators - The People's Bank of China reported a bond market custody balance of CNY 197.7 trillion as of the end of January[7] - The U.S. 10-year Treasury yield is at 4.0479%, down 0.40 basis points over five days[24] Commodity Prices - New York crude oil prices rose by 4.67% to USD 74.56 per barrel, with a year-to-date increase of 30.76%[5] - Gold futures decreased by 3.54%, but are up 18.54% year-to-date[5] Investment Recommendations - Longyuan Power is highlighted as a beneficiary of green energy policies, with a forecasted P/E ratio of 8.5 and a dividend yield of approximately 3.1%[16] - The report suggests a buy on New China Life (2628.HK) at HKD 25.5, with a target price of HKD 28.5, indicating a potential upside of 11.8%[12]

Economic Overview - China's manufacturing PMI rose to 49.2, indicating a contraction for the eighth consecutive month[2] - Hong Kong's Hang Seng Index closed at 25,858.89, down 0.34% for the day and up 28.91% year-to-date[5] Market Performance - The average first-day gain for new stocks in November was 32%, but the market is cooling[2] - The total turnover in Hong Kong was HKD 146.204 billion, a decrease of 28.6% from the previous day[7] Sector Analysis - The technology index increased by 0.02%, while the financial index decreased by 0.63%[5] - Pharmaceutical stocks faced selling pressure, with WuXi AppTec down 3.8% and Hansoh Pharmaceutical down 2%[7] Investment Recommendations - For Misse Group (2097.HK), a buy recommendation at HKD 420 with a target price of HKD 450 was suggested, with a stop-loss at HKD 390[16] - The Chinese ready-to-drink tea market is projected to reach CNY 354.72 billion by 2024, indicating growth potential for Misse Group[14] Global Market Insights - The Dow Jones Industrial Average rose by 0.61% to 47,716.42, while the S&P 500 and Nasdaq increased by 0.54% and 0.65%, respectively[7] - The U.S. dollar index decreased by 0.03% year-to-date, down 8.35% overall[5]